Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI-RS 2025

Jalesh N Panicker1,2, Chris Harding3,4, Hashim Hashim5

  • 1Department of Uro‑Neurology, The National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, UK.

PubMed
Summary

Precise patient phenotyping is key to predicting sacral neuromodulation/sacral nerve stimulation (SNM/SNS) success in dysfunctional voiding (DV). Future research should refine patient selection criteria for better outcomes.